Key facts
- Envision Health Technologies’s last known valuation is $22.5M (Sep 2025).
- It has raised $2.4M across 1 recorded rounds; the latest was Seed Round ($1.6M) in Sep 2025.
- Envision Health Technologies has filed 1 Form D with the SEC, most recently Oct 2025 ($1.6M sold to 2 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Envision Health Technologies
Funding rounds
1 roundsAbout Envision Health Technologies
Developer of assistive technology devices designed to support individuals with visual impairments in daily activities. The company offers wearable devices that use computer vision and audio feedback for navigation, object and text recognition, and situational awareness, enabling people with vision loss to navigate environments safely and supporting accessibility for users and organizations.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2022
- Website
- envisionhealthtech.com/
- Ownership
- Privately Held (backing)
Envision Health Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Envision Health Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Envision Health Technologies in its N-PORT filings yet. We sweep new filings monthly.